Evidence map›Paper›PMID 32538860›Full record

ArticleJournal of neuromuscular diseases2020

Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.

Abhinandan Batra, Donovan J Lott, Rebecca Willcocks, Sean C Forbes, William Triplett, Jahannaz Dastgir, Pomi Yun, A Reghan Foley, Carsten G Bönnemann, Krista Vandenborne and 1 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of neuromuscular diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05618080 active not recruitingnot on this mapstarted 2024, after this paper: background citation

GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1

TypeobservationalSponsorVirginia Commonwealth UniversityRan2024 to 2028Enrolled100ConditionsCalpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A, Limb Girdle Muscular Dystrophy, Limb Girdle Muscular Dystrophy Type R1, LGMD2A
NCT05989620 recruitingnot on this mapstarted 2023, after this paper: background citation

Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)

TypeobservationalSponsorVirginia Commonwealth UniversityRan2023 to 2029Enrolled1,000ConditionsLGMD1B, LGMD1C, LGMD1D, LGMD1E
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. CRISPR/Cas9-Mediated Allele-Specific Disruption of a DominantInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Abhinandan BatraDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Donovan J LottDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Rebecca WillcocksDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Sean C ForbesDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
William TriplettDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Jahannaz DastgirNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Pomi YunNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
A Reghan FoleyNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Carsten G BönnemannNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Krista VandenborneDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Glenn A WalterDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, Florida, USA.
University of Florida · USNational Institutes of Health · US

Funding

Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
Magnetic Resonance Imaging and Biomarkers for Muscular DystropyR01AR056973 · NIAMS · UNIVERSITY OF FLORIDA · PI VANDENBORNE, KRISTA H · 2010 to 2024
$20.2M
Understanding and Improving Therapies for the Muscular Dystrophies through Noninvasive BiomarkersP50AR052646 · NIAMS · UNIVERSITY OF FLORIDA · PI WALTER, GLENN · 2021 to 2024
$6.2M
NIAMS NIH HHS P50 AR052646NIAMS NIH HHS R01 AR056973NIAMS NIH HHS U54 AR052646
6 · The paper itself

Abstract

Collagen VI-related dystrophies (COL6-RDs) and Duchenne muscular dystrophy (DMD) cause progressive muscle weakness and disability. COL6-RDs are caused by mutations in the COL6 genes (COL6A1, COL6A2 and COL6A3) encoding the extracellular matrix protein collagen VI, and DMD is caused by mutations in the DMD gene encoding the cytoplasmic protein dystrophin. Both COL6-RDs and DMD are characterized by infiltration of the muscles by fatty and fibrotic tissue. This study examined the effect of disease pathology on skeletal muscles in lower extremity muscles of COL6-RDs using timed functional tests, strength measures and qualitative/ quantitative magnetic resonance imaging/spectroscopy measures (MRI/MRS) in comparison to unaffected (control) individuals. Patients with COL6-RD were also compared to age and gender matched patients with DMD.Patients with COL6-RD presented with a typical pattern of fatty infiltration of the muscle giving rise to an apparent halo effect around the muscle, while patients with DMD had evidence of fatty infiltration throughout the muscle areas imaged. Quantitatively, fat fraction, and transverse relaxation time (T2) were elevated in both COL6-RD and DMD patients compared to unaffected (control) individuals. Patients with COL6-RD had widespread muscle atrophy, likely contributing to weakness. In contrast, patients with DMD revealed force deficits even in muscle groups with increased contractile areas.

Indexed as

ContractureLower ExtremityMuscle, SkeletalMuscular Dystrophy, DuchenneAdultCollagen Type VICross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleMiddle AgedMuscular DystrophiesCollagen Type VICollagen VI-related dystrophiesduchenne muscular dystrophyforce productionmagnetic resonance imaging

Identifiers

PMID32538860
PMCPMC8603396
OpenAlexW3034962492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.